Health Canada finalises guidance on biosimilars
18 March 2010
Vibha Sharma
Health Canada has issued its much-awaited final guidance on the authorisation of subsequent entry biologics (SEBs), also referred to as biosimilars or follow-on biologics in some jurisdictions.
The final document builds on two draft versions of the guidance, which were issued for public consultation...
Please Login to read the full article.
18 March 2010
Vibha Sharma
The final document builds on two draft versions of the guidance, which were issued for public consultation...
Please Login to read the full article.
RELATED CONTENT
NEWS
- US Capitol Capsule: Obama pushes for crowdfunding, while SEC panel cautious
- 7th Annual Scrip Awards: Novartis, Jimenez, Burrill, Glenmark, ICON win
- Broad swathe of measures to support UK life sciences draws widespread applause
- US Capitol Capsule: IOM focus on affordable 'essential' benefits expected to stir debate on drug prices
EVENTS
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
26 March 2012
Copenhagen, Denmark
JOB OF THE WEEK
Promote your vacancy here
